HOUSTON--(BUSINESS WIRE)--Ensysce Biosciences Inc. announced today the publication of their latest data on their delivery platform for short interfering RNA (siRNA) for therapeutic purposes in the journal Materials. The article, entitled Carbon Nanotubes: Solution for the Therapeutic Delivery of siRNA? highlights the use of carbon nanotubes for therapeutic applications and reports on the recent advances of Ensysce as it moves its technology toward IND enabling studies and a Phase 1 clinical trial.
